NewsBenzingaArmata Pharmaceuticals: BPA del tercer trimestre de $(0,24) supera la estimación de $(0,56); ventas de $3,171 millones superan la estimación de $450.000 mil Armata Pharmaceuticals: BPA del tercer trimestre de $(0,24) supera la estimación de $(0,56); ventas de $3,171 millones superan la estimación de $450.000 mil Benzinga 2026.11.12 21:58 (GMT+0) Open on Benzinga Other news How Tokenized Nvidia Traded Through Two Weeks of Huang Headlines What Are Wall Street Analysts' Target Price for Lumentum Holdings Stock? Texas Pacific Land Stock: Analyst Estimates & Ratings Keybanc Reiterates Sector Weight on NVIDIAto Sector Weight Top 3 Tech Stocks That May Fall Off A Cliff This Month Truist Securities Maintains Hold on BILL Holdings, Raises Price Target to $66